
Please try another search
ExpreS2ion Biotech Holding AB (publ), a biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally. The company’s lead asset is ES2B-C001, a therapeutic vaccine which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2. It is also developing ES2B-I002, a cytomegalovirus vaccine program to treat infectious diseases, as well as vaccines for Nipah virus, Malaria, and influenza. In addition, the company offers a human clinical Phase III-validated technology platform for the development and production of the active material in vaccines under the GlycoX-S2. Further, it out licenses its ExpreS2 platform to research institutes and pharmaceutical companies; and sells ExpreS2 test kits and reagents for research purposes or diagnostic applications. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Martin Roland Jensen | 65 | 2010 | Chairman of the Board |
Rupert Bartsch | - | 2022 | Member of Oncology Scientific Advisory Board |
Mark R. Schleiss | - | 2023 | Member of Infectious Diseases Scientific Advisory Board |
Karin Garre | 68 | 2021 | Independent Director |
Stanley A. Plotkin | 92 | 2023 | Member of Infectious Diseases Scientific Advisory Board |
Allan Randrup Thomsen | - | 2023 | Member of Infectious Diseases Scientific Advisory Board |
Jakob Knudsen | 57 | 2017 | Independent Director |
Giuseppe Curigliano | - | - | Member of Oncology Scientific Advisory Board |
Javier Cortes | - | 2022 | Member of Oncology Scientific Advisory Board |
Sara Sande | 50 | 2021 | Independent Director |
Daniel Lenihan | - | 2022 | Member of Oncology Scientific Advisory Board |
Michael Andersson | - | 2022 | Member of Oncology Scientific Advisory Board |
Lone Graff Stensballe | - | 2023 | Member of Infectious Diseases Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review